These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25661576)

  • 1. Single Institution Experience With Transcatheter Valve-in-Valve Implantation Emphasizing Strategies for Coronary Protection.
    Camboni D; Holzamer A; Flörchinger B; Debl K; Endeman D; Zausig Y; Maier LS; Schmid C; Hilker M
    Ann Thorac Surg; 2015 May; 99(5):1532-8. PubMed ID: 25661576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrodynamic Performance of the Medtronic CoreValve and the Edwards SAPIEN XT Transcatheter Heart Valve in Surgical Bioprostheses: An In Vitro Valve-in-Valve Model.
    Sedaghat A; Sinning JM; Utzenrath M; Ghalati PF; Schmitz C; Werner N; Nickenig G; Grube E; Ensminger S; Steinseifer U; Kuetting M
    Ann Thorac Surg; 2016 Jan; 101(1):118-24. PubMed ID: 26363653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro coronary flow after transcatheter aortic valve-in-valve implantation: A comparison of 2 valves.
    Stock S; Scharfschwerdt M; Meyer-Saraei R; Richardt D; Charitos EI; Sievers HH; Hanke T
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):255-263.e1. PubMed ID: 28104190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves.
    AlBadri A; Joseph J; Patel V; Patel D; Koren O; Cheng W; Jilaihawi H; Makkar R
    JACC Cardiovasc Interv; 2023 Mar; 16(5):542-554. PubMed ID: 36922040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redo procedures for degenerated stentless aortic xenografts and the role of valve-in-valve transcatheter techniques.
    Grubitzsch H; Zobel S; Christ T; Holinski S; Stangl K; Treskatsch S; Falk V; Laule M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):653-659. PubMed ID: 28062549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation.
    Nielsen-Kudsk JE; Andersen A; Therkelsen CJ; Christensen EH; Jensen KT; Krusell LR; Tang M; Terp KA; Klaaborg KE; Greisen JR; Nørgaard BL; Andersen HR
    EuroIntervention; 2017 Oct; 13(9):e1020-e1025. PubMed ID: 28691908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
    Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
    Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of transcatheter valve-in-valve replacement for Mitroflow bioprosthetic valve dysfunction.
    Mosquera VX; González-Barbeito M; Bouzas-Mosquera A; Herrera-Noreña JM; Velasco C; Salgado-Fernández J; Calviño-Santos R; Vázquez-González N; Vázquez-Rodríguez JM; Cuenca-Castillo JJ
    J Card Surg; 2018 Jul; 33(7):356-362. PubMed ID: 29790206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valve-in-valve TAVI and risk of coronary obstruction: Validation of the VIVID classification.
    Tomii D; Okuno T; Lanz J; Stortecky S; Reineke D; Windecker S; Pilgrim T
    J Cardiovasc Comput Tomogr; 2023; 17(2):105-111. PubMed ID: 36754691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprosthesis: Early outcomes.
    Pascual I; Avanzas P; Hernández-Vaquero D; Díaz R; Del Valle R; Padrón R; Lorca R; León V; Martín M; Alfonso F; Morís C
    Int J Cardiol; 2019 Jul; 287():53-58. PubMed ID: 30772015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Reported Successful Femoral Valve-in-Valve Transcatheter Aortic Valve Replacement Using the Edwards Sapien 3 Valve.
    Fournier S; Monney P; Roguelov C; Zuffi A; Iglesias JF; Qanadli SD; Courbon C; Eeckhout E; Muller O
    J Invasive Cardiol; 2015 Oct; 27(10):E220-3. PubMed ID: 26429854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry.
    Conzelmann LO; Würth A; Schymik G; Schröfel H; Anusic T; Temme S; Tzamalis P; Gerhardus J; Mukherjee C; Gonska BD; Schmitt C; Mehlhorn U
    Eur J Cardiothorac Surg; 2018 Oct; 54(4):752-761. PubMed ID: 29617804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valve-in-valve implantation of a novel and small self-expandable transcatheter heart valve in degenerated small surgical bioprostheses: the Hamburg experience.
    Diemert P; Seiffert M; Frerker C; Thielsen T; Kreidel F; Bader R; Schirmer J; Conradi L; Koschyk D; Schnabel R; Reichenspurner H; Blankenberg S; Kuck KH; Treede H; Schaefer U
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):486-93. PubMed ID: 24753352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.
    Khan JM; Dvir D; Greenbaum AB; Babaliaros VC; Rogers T; Aldea G; Reisman M; Mackensen GB; Eng MHK; Paone G; Wang DD; Guyton RA; Devireddy CM; Schenke WH; Lederman RJ
    JACC Cardiovasc Interv; 2018 Apr; 11(7):677-689. PubMed ID: 29622147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valve-in-valve hemodynamics of 20-mm transcatheter aortic valves in small bioprostheses.
    Azadani AN; Jaussaud N; Ge L; Chitsaz S; Chuter TA; Tseng EE
    Ann Thorac Surg; 2011 Aug; 92(2):548-55. PubMed ID: 21704287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-based decision-making treatment of degenerated mitroflow and trifecta prostheses.
    Van Linden A; Blumenstein J; Möllmann H; Kim WK; Walther T; Kempfert J
    Ann Thorac Surg; 2014 Nov; 98(5):1809-13. PubMed ID: 25441789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
    Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry.
    Sathananthan J; Murdoch DJ; Lindman BR; Zajarias A; Jaber WA; Cremer P; Wood D; Moss R; Cheung A; Ye J; Hahn RT; Crowley A; Leon MB; Mack MJ; Webb JG
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1154-1160. PubMed ID: 29929637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Cockburn J; Dooley M; Parker J; Hill A; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):438-444. PubMed ID: 27315455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.